NO984784D0 - Means for inhibiting leukocyte invasion into tissues - Google Patents

Means for inhibiting leukocyte invasion into tissues

Info

Publication number
NO984784D0
NO984784D0 NO984784A NO984784A NO984784D0 NO 984784 D0 NO984784 D0 NO 984784D0 NO 984784 A NO984784 A NO 984784A NO 984784 A NO984784 A NO 984784A NO 984784 D0 NO984784 D0 NO 984784D0
Authority
NO
Norway
Prior art keywords
atoms
tissues
invasion
inhibiting leukocyte
agent
Prior art date
Application number
NO984784A
Other languages
Norwegian (no)
Other versions
NO984784L (en
Inventor
Kay Brune
Rupert Hallmann
Original Assignee
Chephasaar Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19616581A external-priority patent/DE19616581C2/en
Application filed by Chephasaar Gmbh filed Critical Chephasaar Gmbh
Publication of NO984784L publication Critical patent/NO984784L/en
Publication of NO984784D0 publication Critical patent/NO984784D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

An agent for inhibiting leukocyte invasion of tissues contains a hydroxyproline derivative of formula (I), in which R1 and R2 may be the same or different and stand for hydrogen, alkyl groups with 1 to 10 C atoms or an acyl group with 1 to 8 C atoms, R3 stands for a hydroxy, alkoxy or amino group which may have 1 or 2 alkyl substituents with 1 to 4 C atoms or 1 or 2 aryl substituents with 6 to 10 C atoms. Also disclosed is a pharmaceutically acceptable salt of this compound, optionally with other usual pharmaceutical additives and/or auxiliary substances. This agent is useful to prevent and heal damages to tissues caused by invasion and activation of leukocytes.
NO984784A 1996-04-16 1998-10-14 Means for inhibiting leukocyte invasion into tissues NO984784D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19614919 1996-04-16
DE19616581A DE19616581C2 (en) 1996-04-16 1996-04-25 Use of oxaceprol to treat reperfusion damage
PCT/EP1997/001909 WO1997038690A1 (en) 1996-04-16 1997-04-16 Agent for inhibiting leukocyte invasion of tissues

Publications (2)

Publication Number Publication Date
NO984784L NO984784L (en) 1998-10-14
NO984784D0 true NO984784D0 (en) 1998-10-14

Family

ID=26024771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984784A NO984784D0 (en) 1996-04-16 1998-10-14 Means for inhibiting leukocyte invasion into tissues

Country Status (8)

Country Link
EP (1) EP0906096B1 (en)
JP (1) JPH11510515A (en)
AT (1) ATE219671T1 (en)
AU (1) AU2698997A (en)
CZ (1) CZ330498A3 (en)
NO (1) NO984784D0 (en)
PL (1) PL329331A1 (en)
WO (1) WO1997038690A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2946779A1 (en) 2007-02-22 2015-11-25 Beiersdorf AG Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
CL2008001640A1 (en) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Use of hydroxyproline to prepare an alloy composition intended to promote the growth of an animal, such as fish, birds and mammals.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932638A (en) * 1967-09-14 1976-01-13 Franco-Chimie S.A.R.L. Compositions and methods for wound healing
DE1795327C3 (en) * 1967-09-14 1979-09-13 S.A.R.L. Franco-Chimie, Paris Use of N-acetyl-1-hydroxyproline
CA1281288C (en) * 1984-11-05 1991-03-12 Wilhelm Hoerrmann Tumor therapy
IT1248669B (en) * 1990-05-30 1995-01-26 Pulitzer Italiana HYDROXYPROLINE DERIVATE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
JPH05130883A (en) * 1991-11-13 1993-05-28 Kyowa Hakko Kogyo Co Ltd Production of trans-l-hydroxyproline

Also Published As

Publication number Publication date
WO1997038690A1 (en) 1997-10-23
NO984784L (en) 1998-10-14
EP0906096B1 (en) 2002-06-26
EP0906096A1 (en) 1999-04-07
JPH11510515A (en) 1999-09-14
PL329331A1 (en) 1999-03-29
ATE219671T1 (en) 2002-07-15
CZ330498A3 (en) 1999-07-14
AU2698997A (en) 1997-11-07

Similar Documents

Publication Publication Date Title
WO2000021927A3 (en) Pyrrole-2,5-diones as gsk-3 inhibitors
KR950032114A (en) Proline amide derivative
ES2147836T3 (en) DERIVATIVES OF 4,5-DIARILOXAZOLE.
MX9800577A (en) 4,5-diaryl oxazole derivatives.
KR940005597A (en) 4, 1-benzoxazepine derivatives and uses thereof
IL108562A (en) 7, 8-diaryl-1,2,3,4- terahydropyrazolo- £5,1-c| £1,2,4| triazine derivatives, methods for the preparation thereof and pharmaceutical compositions containing them
EA200100766A1 (en) QUINOLIN-2-ON-SUBSTITUTED HETEROAARYNE DERIVATIVES USED AS ANTI-TUMOR AGENTS
MX9700308A (en) Heterobicyclic derivatives.
HUP0103366A2 (en) Amide derivatives which are useful as cytokine inhibitors
HUP0203203A2 (en) Heterocyclic substituted pyrazolones and pharmaceutical compositions containing them
DE69425431T2 (en) 1-AMDINOPHENYL-PYRROLIDONE / PIPERIDINONE AS BLOOD LEAF AGGREGATION INHIBITORS
IE901799L (en) Anti inflammatory aminophenol derivatives
KR960704852A (en) Azole derivatives and pharmaceutical compositions thereof
HUP0001269A2 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
ATE374773T1 (en) POLYCYCLIC COMPOUNDS AS POTENT ALPHA2-ADRENOCEPTOR ANTAGONISTS
KR870700067A (en) Pyrido (2,3-d) -pyrimidine derivatives
DE69718306D1 (en) PIPERIDINYLPYRIMIDINE DERIVATIVES
AU1556997A (en) Chinoline and benzimidazole derivatives as bradykinin agonists
KR970707108A (en) (DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
WO1998004278A3 (en) Tetrapeptide derivatives of dolastatin as antitumor agents
NO984784L (en) Means for inhibiting leukocyte invasion into tissues
KR930006024A (en) Imidazo indolizine derivatives and preparation method thereof
ATE143658T1 (en) PYRROLIDINE DERIVATIVES
KR910020176A (en) Aldose reductase inhibitors
HUP9903399A2 (en) Agent for inhibiting leukocyte invasion of tissues

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application